Biden's Radical Nominee Takes Another Hit From Law Enforcement
Woman Records Very Creepy Visit by the FBI
Joe Biden Is Hitting His Political 'Life Alert' Button With This 2024 Move
South Carolina's Mysterious Bank Account That Has Over $1 Billion in It
Occupied Gaza
Biden Administration Locking Up Public Lands from West to East
Baltimore Mayor Raises Eyebrows Over What He Claims Is His 'Purpose in Life'
Donald Trump: The Non-PC Candidate
Trump's Lawyer Seeks to Dismiss Georgia Case on First Amendment Grounds
Ronald Reagan: The Man Who Cut Taxes From 70 to 28 Percent
Republicans Thwart Democrat Scheme to Raise Gas Prices
The Future Looks...Old?
Not Exactly Something Normal
Senate Judiciary Committee Should Prioritize Main Street Over Wall Street with Free Market...
Some Unpleasant Truths About Islam and the West
Tipsheet

FDA Issues Guidance Prioritizing People for Monoclonal Antibodies Based on Their Race

AP Photo/LM Otero

Guidance from the Food and Drug Administration says that some people may be considered "high risk" based on their race and will be prioritized for monoclonal antibodies and oral antivirals used to treat COVID-19.

Advertisement

The agency issued a fact sheet for healthcare providers, which was updated in December, notifying them that it had approved emergency use authorizations of sotrovimab, a monoclonal antibody proven effective against omicron. However, the antibodies are only approved for patients considered to be "high risk."

"Medical conditions or factors" such as "race or ethnicity" may "place individual patients at high risk for progression to severe COVID-19," the guidance reads, adding that the "authorization of sotrovimab under the EUA is not limited to the medical conditions or factors" outlined by the agency.

Older age, obesity, pregnancy, chronic kidney disease, diabetes, and cardiovascular disease are listed as some of the medical conditions and factors that would make a person "high risk."

Similarly, New York state's Health Department last week revealed its plans to distribute COVID treatments like monoclonal antibody treatment and antiviral pills. The plan states that a person must have "a medical condition or other factors that increase their risk for severe illness" to be eligible for the treatment.

Advertisement

One "risk factor" included in the plan is being a person of color due to "longstanding systemic health and social inequities."

"Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19," the memo reads.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement